ZYNERBA PHARMACEUTICALS INC (ZYNE) Stock Analyst Ratings
NASDAQ:ZYNE - Nasdaq - US98986X1090 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 49% to ZYNE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 1.28. This target is -1.53% below the current price.
ZYNE was analyzed by 9 analysts. The buy percentage consensus is at 49. So analysts seem to be rather neutral about ZYNE.
In the previous month the buy percentage consensus was at a similar level.
ZYNE was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-08-16 | Canaccord Genuity | Downgrade | Buy -> Hold |
| 2023-08-15 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2022-06-23 | Canaccord Genuity | Maintains | Buy |